Amlodipine besylate/atorvastatin calcium single pill combination

DRUG2 trials

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions

DyslipidemiaHypercholesterolemiaHypertension

Phase 4

Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors

CompletedNCT00407537

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Hypercholesterolemia, Hypertension

Start: 2007-03-31End: 2009-10-31Updated: 2021-01-28

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk

CompletedNCT00412113

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Dyslipidemia, Hypertension

Start: 2007-01-31End: 2008-04-30Updated: 2021-02-11

Related Papers

Proactive multifactorial intervention strategy reduces the risk of cardiovascular disease estimated with region-specific risk assessment models in Pacific Asian patients participating in the CRUCIAL trial.

2013-11-262 citations

Proactive cardiovascular risk management versus usual care in patients with and without diabetes mellitus: CRUCIAL trial subanalysis.

2012-07-011 citations

Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial.

2011-02-1034 citations